Showing results (221-230 of 361) with videos related to
Sort By:
Pageof 37
British Medical Journal|November 25, 1972
Treatment of acute myeloblastic leukaemia with RP 22050C Jacquillat, M Weil, M F Gemon, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatmentP Brice, E Lepage, C Gisselbrecht, et al.Leukemia & Lymphoma|August 1, 1993
Isolated peripheral nerve relapse masquerading as Guillain-Barré syndrome in a patient with acute lymphoblastic leukemiaJ M Boiron, E Ellie, A Vital, et al.La Nouvelle Presse Medicale|February 11, 1978
[The action of antilymphocyte serum in severe aplastic anemia (author's transl)]E Gluckman, A Devergie, A Faille, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive casesE Cvitkovic, M Bachouchi, H Boussen, et al.Sarcoma|January 1, 1997
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue SarcomaH J Keizer, D Crowther, O S Nielsen, et al.Journal of Virology|March 1, 1990
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23M Cordier, A Calender, M Billaud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patientsK Fizazi, N Dohollou, J Y Blay, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.Pageof 37